Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma
Recruiting · NCT07564570 · Registry updated 2026-05-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not applicable | 2026-05-04 | NCT07564570 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Universitätsklinikum Hamburg-Eppendorf | 136 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Medical Center Hamburg-Eppendorf | Hamburg | Germany | 7 |